Toll Free: 1-888-928-9744
Published: May, 2015 | Pages:
29 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Novabiotics Ltd - Product Pipeline Review - 2015 Summary Global Markets Direct's, 'Novabiotics Ltd - Product Pipeline Review - 2015', provides an overview of the Novabiotics Ltd's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Novabiotics Ltd's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Novabiotics Ltd including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Novabiotics Ltd's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Novabiotics Ltd's pipeline products Reason to Buy - Evaluate Novabiotics Ltd's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Novabiotics Ltd in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Novabiotics Ltd's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Novabiotics Ltd and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Novabiotics Ltd - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Explore the dormant and discontinued projects of Novabiotics Ltd and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Novabiotics Ltd Snapshot 5 Novabiotics Ltd Overview 5 Key Information 5 Key Facts 5 Novabiotics Ltd - Research and Development Overview 6 Key Therapeutic Areas 6 Novabiotics Ltd - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Novabiotics Ltd - Pipeline Products Glance 10 Novabiotics Ltd - Clinical Stage Pipeline Products 10 Phase II Products/Combination Treatment Modalities 10 Phase I Products/Combination Treatment Modalities 11 Novabiotics Ltd - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Discovery Products/Combination Treatment Modalities 13 Novabiotics Ltd - Drug Profiles 14 cysteamine IR 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 NP-213 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 NP-339 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 NP-432 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Synthetic Peptide for Acne Vulgaris 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Synthetic Peptide for Polymicrobial Infections 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Novabiotics Ltd - Pipeline Analysis 21 Novabiotics Ltd - Pipeline Products by Target 21 Novabiotics Ltd - Pipeline Products by Route of Administration 22 Novabiotics Ltd - Pipeline Products by Molecule Type 23 Novabiotics Ltd - Pipeline Products by Mechanism of Action 24 Novabiotics Ltd - Recent Pipeline Updates 25 Novabiotics Ltd - Dormant Projects 26 Novabiotics Ltd - Locations And Subsidiaries 27 Head Office 27 Other Locations & Subsidiaries 27 Appendix 28 Methodology 28 Coverage 28 Secondary Research 28 Primary Research 28 Expert Panel Validation 28 Contact Us 28 Disclaimer 29
List of Tables
Novabiotics Ltd, Key Information 5 Novabiotics Ltd, Key Facts 5 Novabiotics Ltd - Pipeline by Indication, 2015 7 Novabiotics Ltd - Pipeline by Stage of Development, 2015 8 Novabiotics Ltd - Monotherapy Products in Pipeline, 2015 9 Novabiotics Ltd - Phase II, 2015 10 Novabiotics Ltd - Phase I, 2015 11 Novabiotics Ltd - Preclinical, 2015 12 Novabiotics Ltd - Discovery, 2015 13 Novabiotics Ltd - Pipeline by Target, 2015 21 Novabiotics Ltd - Pipeline by Route of Administration, 2015 22 Novabiotics Ltd - Pipeline by Molecule Type, 2015 23 Novabiotics Ltd - Pipeline Products by Mechanism of Action, 2015 24 Novabiotics Ltd - Recent Pipeline Updates, 2015 25 Novabiotics Ltd - Dormant Developmental Projects,2015 26 Novabiotics Ltd, Subsidiaries 27
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.